High-dose vitamin D does not slow MS lesion development
Taking a high-dose vitamin D supplement as an add-on to standard treatment for multiple sclerosis (MS)…
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Taking a high-dose vitamin D supplement as an add-on to standard treatment for multiple sclerosis (MS)…
People with a certain type of genetic makeup who’ve have head trauma may have a risk of developing multiple…
The level of proteins called kappa free light chains in the cerebrospinal fluid (CSF) — the liquid that surrounds the…
Myrobalan Therapeutics has secured $24 million in series A financing to support the development of oral medications for…
Engaging in online sessions of compassion-focused therapy, which works toward getting people to become more compassionate about themselves, may help…
Six of eight patients with nonactive secondary progressive multiple sclerosis (SPMS) being treated with foralumab nasal spray —…
Adults with multiple sclerosis (MS) or traumatic brain injury report more cognitive fatigue, or exhaustion resulting from mental work,…
A six-month telehealth program designed to help participants change their dietary and lifestyle habits resulted in an increased level of…
Fewer men than women are diagnosed with multiple sclerosis (MS) in China — as elsewhere — but more male…
More than one-third of neurologists in the U.S. believe Bruton’s tyrosine kinase (BTK) inhibitors could be of pivotal significance as…
Taking a ginger supplement eased constipation, nausea, bloating, and abdominal pain in people with relapsing-remitting multiple sclerosis (RRMS) who…
People with multiple sclerosis (MS) are more likely to experience depression, sexual dysfunction, constipation, inflammation of the bladder, and urinary…
Treatment with Mavenclad (cladribine) over two years significantly improved physical and mental health aspects of quality of life in…
People with primary progressive multiple sclerosis (PPMS) at younger ages are more likely to have higher disease activity, suggesting…
The Patent and Trademark Office intends to grant a U.S. patent covering all dosing regimens of vidofludimus calcium —…
COVID-19 doesn’t appear to increase the likelihood of a relapse, where new symptoms suddenly appear or existing ones worsen, for…
Central neuropathic pain — the kind resulting from damage to the brain and spinal cord — appears to be more…
A high level of adherence to disease-modifying therapies (DMTs) is associated with a significant, 25% lower risk of moderate…
Immunic Therapeutics has been notified of the intent to grant a U.S. patent covering the use vidofludimus…
Combining a saffron supplement and an exercise program for three months was seen to significantly ease depression and improve quality…
Neural Sleeve, a bionic piece of clothing by Cionic designed to help with walking and strength, is among…
Low blood levels of vitamin D are tied to poorer cognitive skills and more severe disability in people with…
Socioeconomic factors, specifically income and education levels, and marital status, were identified as risk factors for multiple sclerosis (MS) severity…
People with multiple sclerosis (MS) who develop progressive multifocal leukoencephalopathy (PML)Â as a side effect of Tysabri (natalizumab) often…
Anxiety, depression, and other mental health issues are nearly twice as common in people with multiple sclerosis (MS) in…
People with multiple sclerosis (MS) who experience a greater number of more severe flare-ups, also known as relapses, are…
The rate of brain atrophy, or volume loss, may help in determining whether disease-modifying therapies (DMTs) are slowing disability…
Certain COVID-19 vaccines do not appear to worsen the symptoms of multiple sclerosis (MS), and may provide protection for…
People with multiple sclerosis (MS) in the U.S. who have access to a Shields Health Solutions care model…
Four researchers working in multiple sclerosis (MS) were awarded incubator grants in MS Australia’s latest funding round, which…
Get regular updates to your inbox.